Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03991169
PHASE4

Oral Iron in Children With Chronic Kidney Disease

Sponsor: Weill Medical College of Cornell University

View on ClinicalTrials.gov

Summary

This is a pilot clinical trial of oral iron therapy in children with chronic kidney disease (CKD) and mild anemia. Eligible children will be randomized into a standard of care (iron sulfate) arm vs. no iron therapy arm for 3 months. The outcomes will include muscle strength, physical activity, and changes in eating behavior, which will be measured at enrollment and at the end of the study period.

Official title: Pilot Pragmatic Clinical Trial of Oral Iron Therapy in Children With Chronic Kidney Disease

Key Details

Gender

All

Age Range

1 Year - 21 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2019-04-19

Completion Date

2028-12-31

Last Updated

2025-08-11

Healthy Volunteers

No

Interventions

DRUG

Ferrous Sulfate

Oral iron will be given in the form of immediate-release iron sulfate, 3-6 mg/kg/day of elemental iron to children with body weight ≤43 kg, and 65 mg of elemental iron (325 mg of iron sulfate) to children with body weight \>43 kg.

Locations (2)

Weill Cornell Medicine / New York Presbyterian Hospital

New York, New York, United States

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States